Form 4: BiomX Inc. Director Eddie Williams Reports Stock Option Grant
SEC Form 4
Director Eddie Williams reports acquisition of stock options in BiomX Inc.
Summary
- On July 11, 2024, Eddie Williams, a director of BiomX Inc., reported the acquisition of 176,000 common stock options.
- The options have an exercise price of $0.363.
- The options vest over four years, with 25% vesting on July 11, 2025, and the remainder vesting in 12 equal quarterly installments over three years.
- The expiration date for these options is July 11, 2034.
- Following the transaction, Williams directly owns 176,000 derivative securities.
Sentiment
Score: 6
Explanation: The document is a routine disclosure of stock option grants, which is generally neutral. It indicates alignment of interests between management and shareholders.
Positives
- The grant of stock options to a director aligns their interests with those of the shareholders, incentivizing them to work towards the company's success.
Industry Context
This is a standard practice for compensating and incentivizing directors in publicly traded companies, particularly in the biotech industry.
Stakeholder Impact
- The granting of stock options can potentially impact shareholders by diluting ownership if the options are exercised.
Key Dates
| Date | Description |
|---|---|
| 07/11/2024 | Date of transaction: Eddie Williams acquired 176,000 common stock options. |
| 07/11/2025 | 25% of the options vest. |
| 07/11/2034 | Expiration date of the options. |
| 07/15/2024 | Date of signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.